SCHEMBL6317010

SCHEMBL6317010

Cc1nc2c(nc1NCc1ccccc1)c(=O)n(C)c(=O)n2C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.63
LMNA P02545 3/20 0.63
CASP1 P29466 2/20 0.63
HSD17B10 Q99714 2/20 0.63
CASP7 P55210 1/20 0.63
TSHR P16473 1/20 0.57
MAPT P10636 5/20 0.54
ALDH1A1 P00352 4/20 0.52
HPGD P15428 2/20 0.52
MEN1 O00255 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 1/20 0.52
USP2 O75604 2/20 0.51
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 2/20 0.47
PKM P14618 1/20 0.47
HIF1A Q16665 1/20 0.47
GLA P06280 1/20 0.47
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314771 0.83 KDM4E (0.58) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL5448291 0.71 ALDH1A1 (0.73) KDM4ELMNAMAPTALDH1A1HPGD
SCHEMBL10369640 0.71 ALOX15 (0.80) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL3668402 0.69 KDM4E (1.00) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL7526429 0.68 KDM4E (0.78) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL6323491 0.68 KDM4E (0.64) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL6321065 0.68 RXFP1 (0.54) KDM4ELMNACASP1HSD17B10CASP7
SCHEMBL26312966 0.67 ALDH1A1 (0.66) KDM4ELMNAMAPTALDH1A1HPGD
SCHEMBL6323397 0.67 KDM4E (0.54) KDM4ELMNAHSD17B10MAPTALDH1A1
SCHEMBL4799956 0.67 RXFP1 (0.60) LMNAHSD17B10TSHRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 KDM4E 1278/4885LMNA 3699/4885CASP1 2133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.